New corporate member

IPC is pleased to welcome Arcutis Biotherapeutics, Inc. as a 2022 Bronze Level Corporate Member. Arcutis, based in Westlake Village, CA, is a medical dermatology company founded in 2016 that champions meaningful innovation to solve the most persistent challenges of patients with immune-mediated dermatological diseases and conditions. “We are delighted to welcome Arcutis Biotherapeutics, Inc. to the IPC family, and look forward to partnering with them to improve the care of people with psoriasis worldwide, through education, research and advocacy,” said IPC CEO Christy Langan.

More information about Arcutis can be found at https://www.arcutis.com/.